dc.contributor.author | Yavuz, Bunyamin | |
dc.contributor.author | Ata, Naim | |
dc.contributor.author | Oto, Emre | |
dc.contributor.author | Katircioglu-Ozturk, Deniz | |
dc.contributor.author | Aytemir, Kudret | |
dc.contributor.author | Evranos, Banu | |
dc.contributor.author | Koselerli, Rasim | |
dc.contributor.author | Ertugay, Emre | |
dc.contributor.author | Burkan, Abdulkadir | |
dc.contributor.author | Ertugay, Emrah | |
dc.contributor.author | Gale, Christ P. | |
dc.contributor.author | Camm, A. John | |
dc.contributor.author | Oto, Ali | |
dc.date.accessioned | 2019-12-10T11:21:41Z | |
dc.date.available | 2019-12-10T11:21:41Z | |
dc.date.issued | 2017 | |
dc.identifier.issn | 1099-5129 | |
dc.identifier.uri | https://doi.org/10.1093/europace/euw385 | |
dc.identifier.uri | http://hdl.handle.net/11655/15503 | |
dc.description.abstract | Aims Although atrial fibrillation (AF) is increasingly common in developed countries, there is limited information regarding its demographics, co-morbidities, treatments and outcomes in the developing countries. We present the profile of the TuRkish Atrial Fibrillation (TRAF) cohort which provides real-life data about prevalence, incidence, comorbidities, treatment, healthcare utilization and outcomes associated with AF Methods and results The TRAF cohort was extracted from MEDULA, a health insurance database linking hospitals, general practitioners, pharmacies and outpatient clinics for almost 100% of the inhabitants of the country. The cohort includes 507 136 individuals with AF between 2008 and 2012 aged >18 years who survived the first 30 days following diagnosis. Of 507 136 subjects, there were 423 109 (83.4%) with non-valvular AF and 84 027 (16.6%) with valvular AF. The prevalence was 0.80% in non-valvular AF and 0.28% in valvular AF; in 2012 the incidence of non-valvular AF (0.17%) was higher than valvular AF (0.04%). All-cause mortality was 19.19% (97 368) and 11.47% (58 161) at 1-year after diagnosis of AF. There were 35 707 (7.04%) ischaemic stroke/TIA/thromboembolism at baseline and 34 871 (6.87%) during follow-up; 11 472 (2.26%) major haemorrhages at baseline and 10 183 (2.01%) during follow-up, and 44 116 (8.69%) hospitalizations during the follow-up Conclusion The TRAF cohort is the first population-based, whole-country cohort of AF epidemiology, quality of care and outcomes. It provides a unique opportunity to study the patterns, causes and impact of treatments on the incidence and outcomes of AF in a developing country. | |
dc.language.iso | en | |
dc.publisher | Oxford Univ Press | |
dc.relation.isversionof | 10.1093/europace/euw385 | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.subject | Cardiovascular System & Cardiology | |
dc.title | Demographics, Treatment And Outcomes Of Atrial Fibrillation In A Developing Country: The Population-Based Turkish Atrial Fibrillation (Traf) Cohort | |
dc.type | info:eu-repo/semantics/article | |
dc.type | info:eu-repo/semantics/publishedVersion | |
dc.relation.journal | Europace | |
dc.contributor.department | Kardiyoloji | |
dc.identifier.volume | 19 | |
dc.identifier.issue | 5 | |
dc.identifier.startpage | 734 | |
dc.identifier.endpage | 740 | |
dc.description.index | WoS | |